데이터가 없습니다.

1. Diagnostic accuracy of 18F-FP-CIT PET for clinically uncertain Parkinsonian syndrome [ SCIENTIFIC REPORTS ] - 2023.09.13
2. [F-18]THK-5351 PET Patterns in Patients With Alzheimer's Disease and Negative Amyloid PET Findings [ JOURNAL OF CLINICAL NEUROLOGY ] - 2022.07.01
3. Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival [ BRITISH JOURNAL OF SURGERY ] - 2021.12.19
4. Diagnostic accuracy of dual-phase 18 F-FP-CIT PET imaging for detection and differential diagnosis of Parkinsonism [ SCIENTIFIC REPORTS ] - 2021.07.22
5. Combination of automated brain volumetry on MRI and quantitative tau deposition on THK-5351 PET to support diagnosis of Alzheimer's disease [ SCIENTIFIC REPORTS ] - 2021.05.14
6. A 4-Year Follow-Up of Subjects with Visually Equivocal Amyloid Positron Emission Tomography Findings from the Alzheimer's Disease Neuroimaging Initiative Cohort [ Nuclear Medicine and Molecular Imaging ] - 2021.04.01
7. Test-retest reproducibility of dopamine transporter density measured with [18F]FP-CIT PET in patients with essential tremor and Parkinson's disease [ ANNALS OF NUCLEAR MEDICINE ] - 2021.01.02
8. Immune microenvironment of the gene signature reflecting the standardised uptake value on ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography in head and neck squamous cell carcinoma [ ANNALS OF NUCLEAR MEDICINE ] - 2021.01.01
9. Clinical Evaluation of(18)F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With(18)F-THK-5351 [ CLINICAL NUCLEAR MEDICINE ] - 2020.11.01
10. Clinicopathological characteristics of primary central nervous system lymphoma with low 18F-fludeoxyglucose uptake on brain positron emission tomography [ MEDICINE ] - 2020.05.15
11. The clinical feasibility of deep learning-based classification of amyloid PET images in visually equivocal cases [ EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ] - 2020.02.01
12. Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer's disease differ according to disease severity and amyloid positivity [ PLoS One ] - 2019.12.12
13. Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson’s disease with mild cognitive impairment [ NUCLEAR MEDICINE COMMUNICATIONS ] - 2019.12.01
14. Bilirubin-Related Differential Striatal [18F]FP-CIT Uptake in Parkinson Disease [ CLINICAL NUCLEAR MEDICINE ] - 2019.11.01
15. Differences in gray and white matter F-18-THK5351 uptake between behavioral-variant frontotemporal dementia and other dementias [ EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ] - 2019.02.01
16. The presence of depression in de novo Parkinson's disease reflects poor motor compensation [ PLoS One ] - 2018.09.19
17. Clinical significance of visually equivocal amyloid PET findings from the Alzheimer's Disease Neuroimaging Initiative cohort [ NEUROREPORT ] - 2018.05.02
18. Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia. [ EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ] - 2018.03.01
19. Longitudinal Decline of Striatal Subregional [18F]FP-CIT Uptake in Parkinson’s Disease [ Nuclear Medicine and Molecular Imaging ] - 2017.12.01
20. Different subregional metabolism patterns in patients with cerebellar ataxia by 18F-fluorodeoxyglucose positron emission tomography [ PLoS One ] - 2017.03.20
21. Optimized Statistical Parametric Mapping for Partial-Volume-Corrected Amyloid Positron Emission Tomography in Patients with Alzheimer’s Disease and Lewy Body Dementia [ JOURNAL OF THE KOREAN PHYSICAL SOCIETY ] - 2017.03.01
22. Additional Value of Early-Phase 18F-FP-CIT PET Image for Differential Diagnosis of Atypical Parkinsonism [ CLINICAL NUCLEAR MEDICINE ] - 2017.02.07
23. Striatofrontal deafferentiation in MSA-P: Evaluation with [18F]FDG Brain PET [ PLoS One ] - 2017.01.13
24. Subregional Pattern of Striatal Dopamine Transporter Loss on F-18 FP-CIT Positron Emission Tomography in Patients With Pure Akinesia With Gait Freezing [ JAMA NEUROLOGY ] - 2016.12.01
25. Different loss of dopamine transporter according to subtype of multiple system atrophy [ EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ] - 2016.03.01
26. Is normosmic Parkinson disease a unique clinical phenotype? [ NEUROLOGY ] - 2015.10.13
27. Software development for ACR-approved phantom-based nuclear medicine tomographic image quality control with cross-platform compatibility [ JOURNAL OF THE KOREAN PHYSICAL SOCIETY ] - 2015.07.01
28. The Effect of SSRIs on the Binding of 18F-FP-CIT in Parkinson Patients: A Retrospective Case Control Study [ Nuclear Medicine and Molecular Imaging ] - 2014.12.01
29. Uneven age effects of [18F]FP-CIT binding in the striatum of Parkinson’s disease [ ANNALS OF NUCLEAR MEDICINE ] - 2014.11.26
30. Evaluation of Selective Positron Emission Tomography Template Method for Spatial Normalization of Amyloid Imaging With 11C-Pittsburgh Compound B [ JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY ] - 2014.11.21
31. Cerebellum-specific 18F-FDG PET analysis for the detection of subregional glucose metabolism changes in spinocerebellar ataxia [ NEUROREPORT ] - 2014.10.22
32. Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease [ NEUROLOGY ] - 2014.05.06
33. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery [ JOURNAL OF NUCLEAR MEDICINE ] - 2014.04.01
34. Differential Diagnosis of Parkinsonism Using Dual-Phase F-18 FP-CIT PET Imaging [ Nuclear Medicine and Molecular Imaging ] - 2013.03.01
35. Subregional patterns of preferential striatal dopamine transporter loss differ in Parkinson disease, progressive supranuclear palsy, and multiple-system atrophy [ JOURNAL OF NUCLEAR MEDICINE ] - 2012.03.01
36. Effect of Animal Condition and Fluvoxamine on the Result of [18F]N-3-Fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) Nortropane ([18F]FP-CIT) PET Study in Mice [ Nuclear Medicine and Molecular Imaging ] - 2012.03.01
37. Diagnostic Usefulness of 3 '-Deoxy-3 '-[#18#F]Fluorothymidine Positron Emission Tomography in Recurrent Brain Tumor [ JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY ] - 2011.11.21
38. Evaluation of Metabolic Characteristics and Viability of Lipiodolized Hepatocellular Carcinomas Using 18F-FDG PET/CT [ JOURNAL OF NUCLEAR MEDICINE ] - 2010.12.01
39. 18F-FDG PET/CT에서 우연히 관찰되는 구개편도의 비대칭적 섭취증가의 임상적 의의 [ 핵의학 분자영상 ] - 2009.10.30
40. Molecular Imaging in Neurodegenerative Diseases [ JOURNAL OF THE KOREAN MEDICAL ASSOCIATION ] - 2009.02.10
41. 도파민 운반체 영상의 임상이용을 위한 실제적 접근 [ 핵의학 분자영상 ] - 2008.12.31
42. F-18 FDG PET/CT에서 우연히 발견된 비인두 결핵 1예 [ 핵의학 분자영상 ] - 2008.12.31
43. 뇌종양에서의 18F-FDG PET의 임상이용 [ 핵의학 분자영상 ] - 2008.12.31
44. 두경부 종양에서 18F-FDG PET의 임상이용 [ 핵의학 분자영상 ] - 2008.12.31
45. F-18 FDG와 C-11 acetate PET에서 서로 다른 섭취를 보인 간 혈관근육지방종 1예 [ 핵의학 분자영상 ] - 2008.06.30
46. 죽상 동맥 경화성 뇌혈관 폐색 환자에서의 두개외강-내강 우회로술후의 혈관 영역별 연속 혈류역학 변화 [ 핵의학 분자영상 ] - 2008.02.28
47. Metabolic Topography of Parkinsonism [ 핵의학 분자영상 ] - 2007.02.01
48. PET Imaging of Serotonin Transporters with [11C]DASB: Test-Retest Reproducibility Using a Multilinear Reference Tissue Parametric Imaging Method [ JOURNAL OF NUCLEAR MEDICINE ] - 2006.02.01
49. [18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors [ EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ] - 2005.06.30
50. 두경부암 환자에서 경부 림프절 전이에 대한 18F-FDG-PET과 CT/MRI의 진단적 정확도 비교: 림프절군에 따른 연구 [ 대한핵의학회지 ] - 2004.03.01
51. 두경부 편평상피세포암종에서 18FDG-PET을 이용한 방사선치료 반응 평가 [ 대한두경부종양학회 ] - 2003.03.01

1. 신경염증 및 치매 영상진단용 중수소치환 방사성의약품 개발과 검증 - 2022.04.01 ~ 2022.12.31
2. 인공지능기반, 인간중심적 핵의학분자영상 고도화 기술 개발 - 2022.03.01 ~ 2023.02.28
3. (2021, 중견) 인공지능기반, 인간중심적 핵의학분자영상 고도화 기술 개발 - 2021.03.01 ~ 2022.02.28
4. 알츠하이머병 환자의 보조진단에 대한 안전성 및 유효성을 평가하기 위한 탐색임상 PET Image 판독 연구 - 2021.01.11 ~ 2025.12.31
5. 파킨슨 병 환자의 치료 유효성과 안전성을 평가하기 위한 PET Image 판독 연구 - 2020.04.27 ~ 2025.12.31
6. 다중영상기반 치매 조기진단 및 예측 융합임상기술 개발 - 2019.07.01 ~ 2019.10.31
7. 뇌전용 PET 임상유용성 평가를 위한 전후향적 임상시험 - 2019.02.01 ~ 2020.01.31
8. 다중영상기반 치매 조기진단 및 예측 융합임상기술 개발 - 2018.09.01 ~ 2019.06.30
9. 뇌전용 PET 임상유용성 평가를 위한 전후향적 임상시험 - 2018.02.01 ~ 2019.01.31
10. 다중영상기반 치매 조기진단 및 예측 융합임상기술 개발 - 2017.11.01 ~ 2018.10.31
11. 알츠하이머병 환자의 선별을 위한 PET Image 판독 연구 - 2017.07.26 ~ 2018.12.31
12. 뇌전용 PET 임상유용성 평가를 위한 전후향적 임상시험 - 2017.05.02 ~ 2018.01.31
13. 다중영상기반 치매 조기진단 및 예측 융합임상기술 개발 - 2016.11.01 ~ 2017.10.31
14. 인지기능이 정상인 지원자와 알츠하이머병 환자에서 양전자방출단층촬영술(PET)을 이용하여 [18F]THK-5351의 약력학적특성과 뇌의 타우(Tau)단백 병리를 평가하기 위한 제1상 임상시험 - 2016.07.21 ~ 2017.08.31
15. 다중영상기반 치매 조기진단 및 예측 융합임상기술 개발 - 2015.11.01 ~ 2016.10.31
16. 뉴라체크주사의 안전성 및 유효성 확인을 위한 사용성적조사 - 2015.10.16 ~ 2020.12.18
17. 다중영상기반 치매 조기진단 및 예측 융합임상기술 개발 - 2014.12.01 ~ 2015.10.31
18. 치매 다기관 PET 뇌영상 연구체계 및 기술 개발 - 2014.11.01 ~ 2015.10.31
19. PET 기반 타우/뇌염증 영상 및 다중MR영상 분석을 통한 치매예측모델 개발을 위한 미래수요예측형 사전기반연구 - 2014.07.21 ~ 2014.10.20
20. 치매 다기관 PET 뇌영상 연구체계 및 기술 개발 - 2013.11.01 ~ 2014.10.31
21. 알츠하이머병의 가능성이 있는(pAD) 또는 기억성경도인지장애(aMCI)가 있는 일본인 피험자와 건강한 지원자를 대상으로 플루트메타몰 F18 주사제의 뇌흡수율과 안전성 평가를 위한 오픈라벨 임상시험 - 2012.12.10 ~ 2013.06.30
22. 치매 다기관 PET 뇌영상 연구체계 및 기술 개발 - 2012.11.01 ~ 2013.10.31
23. 신규 기전의 우울증 치료제에 대한 흰쥐의 뇌 영상 연구 - 2009.12.21 ~ 2013.06.20

1. 초기 동적 영상데이터 기반 진단용 영상 생성방법 및 프로그램 - 2022.12.28
2. 뇌 형상 특징 정량화를 통한 알츠하이머 병 예측 방법, 프로그램 및 컴퓨팅 장치 - 2021.02.04

      데이터가 없습니다.

 공지